Haiyang Yu
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds 7
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 7
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 5
- Molecular Biology top 10%
-
- Immune cells in cancer 9
-
- Autophagy in Disease and Therapy 8
-
- Cancer Immunotherapy and Biomarkers 7
-
- Alcohol Consumption and Health Effects 5
- Co-authors
- Yuling QiuShuangshuang YinQian ChenYingying ShaoTao WangYiman LiuCaiyan LiuKailong Wang
- Journals
- Nano Letters (1 paper)Journal of Hazardous Materials (1 paper)International Journal of Molecular Sciences (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Haiyang Yu
83 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Pharmacology 225
- Cancer Research 327
- Nephrology 129
- Complementary and alternative medicine 122
- Molecular Biology 867
Countries citing papers authored by Haiyang Yu
This map shows the geographic impact of Haiyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyang Yu more than expected).
Fields of papers citing papers by Haiyang Yu
This network shows the impact of papers produced by Haiyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyang Yu. The network helps show where Haiyang Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haiyang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 15 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 0 | |
| 15 | 2023 | 9 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 21 | |
| 18 | 2020 | 29 | |
| 19 | 2018 | 17 | |
| 20 | 2017 | 133 |
About Haiyang Yu
Haiyang Yu is a scholar working on Cancer Research, Pharmacology and Nephrology, having authored 92 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immune cells in cancer (9 papers), Cancer-related molecular mechanisms research (8 papers), Autophagy in Disease and Therapy (8 papers), Pharmacological Effects of Natural Compounds (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), MicroRNA in disease regulation (7 papers), Gout, Hyperuricemia, Uric Acid (5 papers) and Alcohol Consumption and Health Effects (5 papers). The work is most often cited by research in Pharmacology (225 citations), Cancer Research (327 citations) and Nephrology (129 citations). Haiyang Yu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yuling Qiu, Shuangshuang Yin, Qian Chen, Yingying Shao, Tao Wang, Tao Wang, Yiman Liu, Caiyan Liu, Qian Chen and Kailong Wang. Their work appears in journals such as Nano Letters, Journal of Hazardous Materials and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.